Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check3 days agoChange DetectedAdded the CLOVER-2 dose-escalation study title focusing on pediatric solid tumors, including Rhabdomyosarcoma, and updated the revision to v3.5.0. Replaced the previous broader CLOVER-2 description with the new title and scope.SummaryDifference0.5%

- Check10 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check18 days agoChange DetectedUI tweaks and updated timestamps observed; core study details remain unchanged.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded 'Atypical teratoid rhabdoid tumor' to the study's keywords/MeSH terms.SummaryDifference0.0%

- Check32 days agoChange DetectedNo significant changes detected between the two screenshots; core study information and page structure appear unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded revision note v3.4.2 and removed an earlier downtime notice about government funding; this is a minor maintenance update (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.4%

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.